Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Elizabeth Radigan"'
Autor:
John Broach, Olga Brown, Caitlin McEachern, Janell Forget, Peter Lancette, Norman Soucie, Julie Inzerillo, Robert Klugman, Stephen Tosi, Abraham Haddad, Pamela Manor, Richard Bylund, Gio Dellostritto, Max Grecchi, Connie Camelo, Jeanne Shirshac, Katharine Eshghi, Nardy Vega, Stacy Hampson, Kassandra Follwell, Rafael Gonzalez, Theresa Hicks, Victoria McCandless, Timothy VanStratten, Mina Botros, Tracy Jalbert, Catherine Merwin, Wendy Schellhammer, Ian Pelto, Maggie Rodriguez, Cheryl LaPriore, Monica Lowell, Elizabeth Radigan, Lorie Gull, Alana Gruszecki, Sarah Benoit, Eric Dickson, Michelle Muller
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
The SARS CoV-2 (COVID-19) pandemic presented unprecedented challenges as communities attempted to respond to the administration of a novel vaccine that faced cold chain logistical requirements and vaccine hesitancy among many, as well as complicated
Externí odkaz:
https://doaj.org/article/bcaf4fc8241541acac522e10f7ab2883
Autor:
Moamen Al Zoubi, Gail Scully, Maureen Campion, Nicole Theodoropoulos, Iva Zivna, Emily Dionne, Elizabeth Radigan
Publikováno v:
Open Forum Infectious Diseases
Background It is estimated that 30–50% of antimicrobial agents prescribed inpatient are not optimal. Historically, antimicrobial evaluation has been based primarily upon expert opinion of ID trained individuals. Spivak and colleagues proposed stand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec9a1bcf3da968581bb82b916e172a35
http://europepmc.org/articles/PMC6252445
http://europepmc.org/articles/PMC6252445
Publikováno v:
Open Forum Infectious Diseases. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff0ca6efa768e34adf9042710f340ba5
https://doi.org/10.1093/ofid/ofv133.1055
https://doi.org/10.1093/ofid/ofv133.1055
Publikováno v:
Journal of intensive care medicine. 25(6)
Antibacterial resistance is increasing throughout the world, while the development of new agents is slowly progressing. In addition, the increasing prevalence of fluoroquinolone resistance may force many practitioners to choose an aminoglycoside agen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::358d591b7c5d2647de126246579828db
https://pubmed.ncbi.nlm.nih.gov/20837630
https://pubmed.ncbi.nlm.nih.gov/20837630